[1]Shuch B, Amin A, Armstrong AJ ,et al.(2015) Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity.Eur Urol, 67(1): p. 85-97.
[2]Frederik CR, Sandra S,Kerstin J, et al.(2014) Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma.BMJ Cancer.14:p.372-379
[3]Amit J, Arvind S,Vanita N,et al.(2018) Metastatic Renal Cell Cancer-Systemic Therapy. Indian J Surg Oncol,
9(1): p.97-104
[4]Sylman J L,Mitrugno A, Atallah M, et al.(2018) The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis.[J].Front Oncol.8:78-87
[5]
Zhu ML,
Feng M,
He F,et al.(2018) Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer[J]. Clin Chim Acta.483:296-302
[6]Pagano L, Mele C, Sama MT,et al.(2018)Thyroid cancer phenotypes in relation to inflammation and autoimmunity[J].Frontiers in bioscience (Landmark edition). 23: 2267-2282.
[7]Dalpiaz O,Luef T,Seles M,et al.(2017) Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil–lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma[J].British Journal of Cancer.116(1):85-90.
[8]Sekar RR,Patil D,Baum Y,et al.(2017)A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma[J].Asian Journal of Urology.4(4):230-238.
[9]Hu H,Yao XJ,Xie XC,et al.(2017)Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.[J].World Journal of Urology.35(2):261-270.
[10]Guo J,Chen S,Chen Y,et al.(2018)Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer.[J].Cancer Manag Res.10:315-321.
[11] Cao Z, Ji J, Zhang C,et al.(2019) The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy[J].Cancer Medicine. [Epub ahead of print], PMID:30693666.
[12]Karataş M,Gündüzöz M, Öziş TN,et al.(2019)Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as hematologic indices of inflammatory response in ceramic workers' silicosis. Clin Respir J. [Epub ahead of print], PMID:30664328
[13]Semeniuk-Wojta A,Lubas A,Stec R,et al.(2018)Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis[J].Clinical Genitourinary Cancer. 16(3):685-693.
[14]Lucca I,Michela1 DM,Sebastian1 H,et al.(2015)Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma.[J].World journal of urology.33(12):2045-2052.
[15]Chen Z,Shao Y,Yao H,et al.Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients.[J].Oncotarget.2017, 8(29):48291-48302
[16]Grivas N,Vasilios1 K,Ioannis1 T,et al.(2014)Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece[J].Urology Annals.6(2):116–121.
[17]Pichler1 M,Hutterer GC,Stoeckigt1 C,et al.(2013) Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.[J].British Journal of Cancer.108(4):901-907.
[18]Andreas1 S.(2010)Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J].European Journal of Epidemiology.25(9):603-605.
[19]Wen RM,Zhang YJ,Ma S,et al.(2015)Preoperative Neutrophil to Lymphocyte Ratio as a Prognostic Factor in Patients with Non-metastatic Renal Cell Carcinoma.[J].Asian Pac J Cancer Prev.16(9):3703-3708.
[20]Martino MD,Pantuck AJ,Hofbauer S,et al.(2013)Prognostic Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Localized Nonclear Cell Renal Cell Carcinoma[J].Journal of Urology.190(6):1999-2004.
[21]Gu LY,Ma X,Li H,et al.(2016)Prognostic value of preoperative inflammatory response biomarkers in patients with sarcomatoid renal cell carcinoma and the establishment of a nomogram[J].Scientific Reports.6:23846-23855.
[22]Viers BR,Thompson RH,Boorjian SA,et al.(2014)Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy[J].Urologic Oncology.32(8):1277-1284.
[23]Diakos CI, Charles KA, McMillan DC,et al.(2014)Cancer-related inflammation and treatment effectiveness[J]. Lancet Oncol. 15(11):493-503
[24]Marcela Alcântara Proença, Joice Matos Biselli, Maysa Succi,et al.(2018) Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis[J].World J Gastroenterol. 2018,24(47):5351-5365.
[25]Jadwiga1 J, Sara1 L, Kathrin1 W, et al.(2010)Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model.[J].Journal of Clinical Investigation.120(4):1151-1164.
[26]Guo SJ, Xue YF, He QM, et al.(2017)Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma[J].Plos one. 12(6):178823-178841